scholarly article | Q13442814 |
P356 | DOI | 10.1016/J.BBRC.2016.04.099 |
P698 | PubMed publication ID | 27107695 |
P2093 | author name string | Peng Zhang | |
Dexin Kong | |||
Zhengrong Wang | |||
Kaifeng Wang | |||
Gongying Chen | |||
Yaohua Fan | |||
P433 | issue | 2 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | hepatocellular carcinoma | Q1148337 |
P304 | page(s) | 330-337 | |
P577 | publication date | 2016-04-21 | |
P1433 | published in | Biochemical and Biophysical Research Communications | Q864228 |
P1476 | title | MEK-ERK inhibition potentiates WAY-600-induced anti-cancer efficiency in preclinical hepatocellular carcinoma (HCC) models. | |
P478 | volume | 474 |
Q47103348 | ERK inhibition sensitizes CZ415-induced anti-osteosarcoma activity in vitro and in vivo |
Q55440708 | FABP4 suppresses proliferation and invasion of hepatocellular carcinoma cells and predicts a poor prognosis for hepatocellular carcinoma. |
Q92382925 | FIBCD1 overexpression predicts poor prognosis in patients with hepatocellular carcinoma |
Q47156516 | Jujube leaf green tea extracts inhibits hepatocellular carcinoma cells by activating AMPK. |
Q37664313 | Lymphocyte-specific protein 1 inhibits the growth of hepatocellular carcinoma by suppressing ERK1/2 phosphorylation |
Q41549602 | Tumor-specific hepatic stellate cells (tHSCs) induces DIgR2 expression in dendritic cells to inhibit T cells |
Search more.